Patients in Good Health Clinical Trial
Official title:
Inflammatory Cytokines Profile in Individuals Subjected to Surgical Procedures Using Propofol or Isoflurane.
Verified date | April 2010 |
Source | UPECLIN HC FM Botucatu Unesp |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
The aim of this study is to assess the profile of cytokines IL-1beta, IL-6, IL-8, IL-10, IL-12 and TNF-alpha under inhalation anesthesia with isoflurane and intravenous anesthesia with propofol in healthy patients subjected to minimally invasive elective surgeries.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Patients in good health American Society of Anesthesia status physical I - Elective minor surgery - General anesthesia Exclusion Criteria: - Smokers - Alcoholics - Previous medication or radiation |
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Brazil | Botucatu Medical School, UNESP | Botucatu | São Paulo |
Lead Sponsor | Collaborator |
---|---|
UPECLIN HC FM Botucatu Unesp | Fundação de Amparo à Pesquisa do Estado de São Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of cytokines profile | Before surgery and anesthesia, 2h after anesthesia and at the following day of the surgery | Yes | |
Secondary | Evaluation of pro and anti-inflammatory cytokines | before surgery and anesthesia, 2h after anesthesia and at the following day of the surgery | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00854178 -
Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery
|
Phase 4 |